By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
The Washington DigestThe Washington Digest
  • Politics
  • Business
  • World
  • Lifestyle
  • Sports
  • Technology
  • Education
  • Contact
  • Submit a News Release
  • About Us
Reading: HHS’ Rachel Levine: Long COVID will affect U.S. for ‘years to come’
Share
Notification Show More
Latest News
Software Development Company Geniusee Expands Its Sales Presence in California
September 15, 2023
Nection’s Networking Revolution: Try the AI-powered gifts and say bye to useless networking!
August 11, 2023
Navigating Brand Success: Philadelphia PR Agencies in the Spotlight
August 8, 2023
Tech PR Agencies: Elevating Your Brand in the Digital Age
July 27, 2023
D.C. Gears Up to Celebrate Independence Day with Spectacular Festivities
June 29, 2023
Aa
Aa
The Washington DigestThe Washington Digest
  • Politics
  • Business
  • World
  • Lifestyle
  • Sports
  • Technology
  • Education
  • Contact
  • Submit a News Release
  • About Us
  • Politics
  • Business
  • World
  • Lifestyle
  • Sports
  • Technology
  • Education
  • Contact
  • Submit a News Release
  • About Us
Have an existing account? Sign In
Follow US
  • Home
  • Advertise
© 2022 Foxiz News Network. Ruby Design Company. All Rights Reserved.
The Washington Digest > Health > HHS’ Rachel Levine: Long COVID will affect U.S. for ‘years to come’
Health

HHS’ Rachel Levine: Long COVID will affect U.S. for ‘years to come’

Beverly Clements
Beverly Clements August 5, 2022
Updated 2022/08/05 at 2:43 AM
Share
SHARE

So-called long COVID infections that leave people with symptoms longer than 12 weeks and new chronic illnesses will likely affect the U.S. for “years to come,” the top deputy at the Department of Health and Human Services warned Wednesday.

Rachel Levine, assistant secretary of health and human services, cited an April 5 Biden administration memo calling for “a whole-of-government response” to address the growing number of Americans whose afflictions outlast the virus.

“It is important to focus a new lens on the pandemic and direct much-needed attention to Long COVID. Taking care of affected patients presents challenges given the incompleteness of research, the lack of sufficient diagnostics support, and pervasive problems with access to services,” Dr. Levine wrote in the Journal of the American Medical Association.

According to a 2022 Centers for Disease Control and Prevention study of 63.4 million health records, 1 in 5 adult COVID-19 survivors aged 18 to 64 years and 1 in 4 survivors 65 and older have lingering health problems “related to their previous COVID-19 illness,” she wrote.

Those problems often target the body’s organs. They include new onset heart disease, diabetes, kidney disease, hematologic disorders, neurologic conditions and mental illnesses like anxiety and depression.

Dr. Levine also cited a parallel modeling study showing that 4.3 million to 9.7 million adults, especially women, “have new long-term symptoms that limit their daily activities after SARS-CoV-2 infection.”

Long COVID survivors have reported extreme fatigue, loss of taste, loss of smell, breathlessness and muscle weakness continuing for months after being infected. In extreme cases, some COVID survivors have been unable to return to work up to six months after infection.

Dr. Levine noted that as of July 26, the U.S. has reported an estimated 90 million COVID infections and 1 million deaths, with omicron subvariants such as BA.5 and BA.4 now the dominant strains.

For more information, visit The Washington Times COVID-19 resource page.

READ NEWS SOURCE

The post HHS' Rachel Levine: Long COVID will affect U.S. for 'years to come' appeared first on thewashingtondigest.com.

You Might Also Like

Healthcare in Washington: Access, Quality, and Public Health Programs

Exploring the Controversy Surrounding Pharmaceutical Marketing Agencies in Washington’s Healthcare Industry

Nurse practitioner says CVS fired her over abortion stance

Sonia Sotomayor denies NYPD detective’s plea to block vaccine mandate

FDA expected to authorize Moderna, Pfizer-BioNTech Omicron boosters

Beverly Clements August 5, 2022
Share this Article
Facebook TwitterEmail Print
Previous Article Kansas landslide fuels abortion rights movement’s next fights
Next Article Pharma group leader says Dems who vote for reconciliation bill ‘won’t get a free pass’
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Latest News

Software Development Company Geniusee Expands Its Sales Presence in California
Business
Nection’s Networking Revolution: Try the AI-powered gifts and say bye to useless networking!
Business
Navigating Brand Success: Philadelphia PR Agencies in the Spotlight
Business
Tech PR Agencies: Elevating Your Brand in the Digital Age
Business

You Might Also Like

Health

Healthcare in Washington: Access, Quality, and Public Health Programs

May 15, 2023
Health

Exploring the Controversy Surrounding Pharmaceutical Marketing Agencies in Washington’s Healthcare Industry

January 4, 2023
Health

Nurse practitioner says CVS fired her over abortion stance

September 1, 2022
Health

Sonia Sotomayor denies NYPD detective’s plea to block vaccine mandate

September 1, 2022
//

In politics, if you want anything said, ask a man; if you want anything done, ask a woman.

Contact Us

If you have any questions please contact us by email:

ask@thewashingtondigest.com

© 2022 thewashingtondigest.com. All Rights Reserved.

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?